Clinical Trial: A Study to Test How BI 1584862 is Taken up in the Blood of People With and Without Liver Problems
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Hepatic Insufficiency
Study Type: INTERVENTIONAL
Official Title: Pharmacokinetics, Safety and Tolerability of BI 1584862 in Male and Female Participants With Different Degrees of Hepatic Impairment (Child-Pugh Class A, B, and C) Compared With Matched Male and Femal
Brief Summary:
This study is open to adults between 18 and 80 years of age. People with a body mass index (BMI) between 18 and 42 kg/m2 can take part. This study includes people with mild, moderate, and severe liver problems, and people without liver problems as a matching control. The purpose of this study is to find out how mild, moderate, and severe liver problems affect how the body handles a medicine called BI 1584862.Participants take BI 1584862 once. Participants with liver problems are treated in a step-by-step approach…
Read more